Divestiture • Life Science

PharmaLogic Acquires Lantheus Puerto Rico Radiopharmacy and PET Manufacturing Facility

On December 3, 2020, PharmaLogic acquired life science company Lantheus Puerto Rico Radiopharmacy and PET Manufacturing Facility from Lantheus Medical Imaging for 18M USD

Acquisition Context
  • This is PharmaLogic’s 1st transaction in the Life Science sector.
  • This is PharmaLogic’s largest (disclosed) transaction.
  • This is PharmaLogic’s 1st transaction in Puerto Rico.

Explore All 789 Divestiture Life Science Deals - Search the Database Free


M&A Deal Summary

Date December 3, 2020
Target Lantheus Puerto Rico Radiopharmacy and PET Manufacturing Facility
Sector Life Science
Buyer(s) PharmaLogic
Sellers(s) Lantheus Medical Imaging
Deal Type Divestiture
Deal Value 18M USD

Target Company

Lantheus Puerto Rico Radiopharmacy and PET Manufacturing Facility

San Juan, Puerto Rico
Lantheus' Puerto Rico Radiopharmacy and PET Manufacturing Facility include both the Lantheus radiopharmacy and PMF businesses located in San Juan, Puerto Rico. The radiopharmacy prepares individual, patient-ready doses of radiopharmaceuticals, and the PMF manufactures the drug product for individual, patient-ready doses of fluorodeoxyglucose (FDG).
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

PharmaLogic

Boca Raton, Florida, United States

Category Company
Founded 1993
Sector Healthcare Services
DESCRIPTION

PharmaLogic operates regional nuclear pharmacies throughout the U.S. which compound and dispense patient-specific intravenous drugs and solutions for use in diagnostic imaging and radiopharmaceutical therapy. PharmaLogic was formed in 1993 and is based in Boca Raton, Florida.


Deal Context for Buyer #
Overall 1 of 2
Sector: Life Science 1 of 2
Type: Divestiture 1 of 1
Country: Puerto Rico 1 of 1
Year: 2020 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-04-09 Agilera

Kjeller, Norway

Agilera partners with pharmaceutical companies for manufacturing commercial radiopharmaceutical therapies across the United States, Europe, and Asia. The company has three business areas: CDMO, CMO, and Wholesaler and distribution. CDMO: Development partner for innovative radiopharmaceuticals from early phase to clinical production, tailored to customer needs. CMO: Commercial production and distribution. Permits from the Norwegian Medicines Agency and GMP certified. Wholesaler and distribution: Agilera is the national wholesaler of radiopharmaceuticals in Norway. It has a central pharmacy function for radiopharmaceuticals and a logistics centre that distributes radiopharmaceuticals throughout Norway and globally. Agilera is based in Kjeller, Norway.

Buy -

Seller Profile 1

SELLER

Lantheus Medical Imaging

Bedford, Massachusetts, United States

Category Company
Founded 1956
Sector Medical Products
Employees808
Revenue 1.5B USD (2024)
DESCRIPTION

Lantheus Medical Imaging is a supplier of radiopharmaceuticals and contrast agents for nuclear and ultrasound-based cardiovascular diagnostic imaging procedures. Lantheus Medical Imaging was founded in 1956 and is based in Bedford, Massachusetts.


Deal Context for Seller #
Overall 1 of 2
Sector: Life Science 1 of 2
Type: Divestiture 1 of 2
Country: Puerto Rico 1 of 1
Year: 2020 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-10-02 Progenics Pharmaceuticals

Tarrytown, New York, United States

Progenics Pharmaceuticals, Inc. is a pharmaceutical company provides medicines to treat disease, focusing on cancer and related conditions with a pipeline that includes product candidates in preclinical through late-stage development. Progenics Pharmaceuticals was founded in 1986 and is based in New York City, New York.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-02-06 Cerveau Technologies

Knoxville, Texas, United States

Cerveau Technologies is a provider of information and technology to researchers and clinicians in order to improve brain health. Cerveau Technologies is based in Knoxville, Texas.

Buy -

Explore Related M&A Activity